These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36685947)

  • 21. A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.
    Zhong L; Zhu J; Shu Q; Xu G; He C; Fang L
    J Oncol; 2023; 2023():5925935. PubMed ID: 36844874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cuproptosis-related lncRNA landscape for predicting the prognosis and aiding immunotherapy in lung adenocarcinoma patients.
    Sun X; Song J; Lu C; Sun X; Yue H; Bao H; Wang S; Zhong X
    Am J Cancer Res; 2023; 13(3):778-801. PubMed ID: 37034212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.
    Liu B; Pang K; Feng C; Liu Z; Li C; Zhang H; Liu P; Li Z; He S; Tu C
    Front Genet; 2022; 13():1063057. PubMed ID: 36568384
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel prognostic model of breast cancer based on cuproptosis-related lncRNAs.
    Li F; Yang Y; Zhang X; Yu J; Yu Y
    Discov Oncol; 2024 Feb; 15(1):35. PubMed ID: 38353835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation.
    Zhou L; Cheng Q; Hu Y; Tan H; Li X; Wu S; Zhou T; Zhou J
    Front Oncol; 2022; 12():1030802. PubMed ID: 36620545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.
    Feng A; He L; Chen T; Xu M
    Front Oncol; 2022; 12():957966. PubMed ID: 36106123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.
    Wang Q; Xu Y
    Front Pharmacol; 2022; 13():1065701. PubMed ID: 36532719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma.
    Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X
    Front Genet; 2022; 13():975905. PubMed ID: 36313456
    [No Abstract]   [Full Text] [Related]  

  • 30. Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer.
    Liu X; Zhou L; Gao M; Dong S; Hu Y; Hu C
    Front Genet; 2022; 13():989646. PubMed ID: 36204323
    [No Abstract]   [Full Text] [Related]  

  • 31. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
    World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer.
    Li J; Wu F; Li C; Sun S; Feng C; Wu H; Chen X; Wang W; Zhang Y; Liu M; Liu X; Cai Y; Jia Y; Qiao H; Zhang Y; Zhang S
    Front Genet; 2022; 13():977322. PubMed ID: 36226193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
    Front Genet; 2022; 13():947551. PubMed ID: 35938003
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma.
    Yu W; Huo H; You Z; Lu R; Yao T; Huang J
    Front Genet; 2022; 13():982888. PubMed ID: 36160008
    [No Abstract]   [Full Text] [Related]  

  • 35. A six-gene prognostic model predicts overall survival in bladder cancer patients.
    Wang L; Shi J; Huang Y; Liu S; Zhang J; Ding H; Yang J; Chen Z
    Cancer Cell Int; 2019; 19():229. PubMed ID: 31516386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma.
    Shi Y; Sheng P; Guo M; Chen K; Zhou H; Wu M; Li W; Li B
    Front Genet; 2023; 14():1100909. PubMed ID: 37470034
    [No Abstract]   [Full Text] [Related]  

  • 37. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T
    Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma.
    Mei W; Liu X; Jia X; Jin L; Xin S; Sun X; Zhang J; Zhang B; Chen Y; Che J; Ma W; Ye L
    Front Genet; 2022; 13():905518. PubMed ID: 36092880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer.
    Qi S; Feng H; Li X
    Front Genet; 2023; 14():1120089. PubMed ID: 37124623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.